WST
WEST PHARMACEUTICAL SERVICES, INC.NYSEResearch view
Healthcare · Surgical & Medical Instruments & Apparatus · Large-cap · SEC EDGAR FY 2025-12-31
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-12-31SectorHealthcare
Market Cap$25.7B
Enterprise Value$25.1B
Income$493.7M
Sales$3.1B
Book/sh$45.13
Cash/sh$11.24
Dividend TTM$0.86
Payout12%
Employees—
IPO—
Quick Ratio2.34
Current Ratio3.02
Debt/Eq0.06
EPS (ttm)$6.79
EPS this Y1.5%
EPS past 3/5Y-4.2%
Sales past 3/5Y2.1%
EPS Y/Y TTM1.5%
Sales Y/Y TTM6.3%
Shs Outstand70.38M
ROA11.6%
ROE15.5%
ROIC18.0%
Gross Margin35.9%
Oper. Margin19.0%
Profit Margin16.1%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$2.8B
2021
$2.9B
2022
$2.9B
2023
$2.9B
2024
$3.1B
2025
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $2.8B | $2.9B | $2.9B | $2.9B | $3.1B |
| Gross Profit | $1.2B | $1.1B | $1.1B | $998.5M | $1.1B |
| Operating Income | $752.3M | $734.0M | $676.0M | $569.9M | $584.9M |
| Net Income | $661.8M | $585.9M | $593.4M | $492.7M | $493.7M |
| Diluted EPS | $8.67 | $7.73 | $7.88 | $6.69 | $6.79 |
| Operating Cash Flow | $584.0M | $724.0M | $776.5M | $653.4M | $754.8M |
| Free Cash Flow | $330.6M | $439.4M | $414.5M | $276.4M | $468.9M |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
FY25 cash-flow waterfall
Capital-light: capex is $285.9M against $754.8M operating cash
COMMUNITY · $WST0 theses
POST YOUR TAKE →Related Stocks
Click to exploreSame Industry · Surgical & Medical Instruments & Apparatus
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.